Trials / Unknown
UnknownNCT01139177
SAMBA EU Femoropopliteal Trial
- Status
- Unknown
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 39 (actual)
- Sponsor
- NovoStent Corporation · Industry
- Sex
- All
- Age
- 21 Years
- Healthy volunteers
- Not accepted
Summary
The primary objective of this study is to evaluate the safety and performance of the SAMBA Stent and Delivery System in the treatment of femoropopliteal lesions.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Stenting of atherosclerotic lesion(s) | Stenting of atherosclerotic lesions post pre-dilatation of lesion(s) |
Timeline
- Start date
- 2009-04-01
- Primary completion
- 2010-09-01
- Completion
- 2010-09-01
- First posted
- 2010-06-08
- Last updated
- 2010-06-08
Locations
2 sites across 1 country: Germany
Source: ClinicalTrials.gov record NCT01139177. Inclusion in this directory is not an endorsement.